论文信息 - Hypothyroidism in the patient with cancer: how much thyroid supplementation is "safe"? - 字舞流文

Hypothyroidism in the patient with cancer: how much thyroid supplementation is "safe"?

P. Davis | A. Hercbergs

[1] L. Rybicki,et al. Association between development of hypothyroidism and improved survival in patients with head and neck cancer. , 2006, Archives of otolaryngology--head & neck surgery.

[2] Hung-Yun Lin,et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. , 2006, Cancer research.

[3] Hung-Yun Lin,et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.

[4] G. Hortobagyi,et al. Thyroid hormone and breast carcinoma , 2005, Cancer.

[5] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[6] G. Barnett,et al. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. , 2003, Anticancer research.